Gilead Sciences Inc. News Finance News & Analysis Nov 3, 2024 7:16 PM EST Fed interest rate decision and election may roil stocks Trump, Harris, the Fed, and a bevy of earnings reports are on deck. PLTRAAPLVRTX Stock Investing News, Analysis and Tips Aug 28, 2024 1:31 PM EDT Stock...
Is Gilead Sciences, Inc. (GILD) the Best Pharma Stock to Buy Right Now? (Insider Monkey) Nov-03-24 07:00AM What To Expect in the Markets This Week (Investopedia) Nov-01-24 09:15AM Ahead of Gilead (GILD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics ...
PROGilead Sciences Is Poised for Long-Term Gains There's more than one way to trade the stock. Market Commentary Jan 2, 2024 5:00 AM EST PROWhat to Expect in January: More Volatility -- And a Correction A month ago there were few in my camp. Now it's getting a little crowded. Le...
GILD Stock 12 Month Forecast Average Price Target $99.29 ▲(8.34% Upside) Based on 26 Wall Street analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $99.29 with a high forecast of $125.00 and a low forecast of $73.00. The ave...
price target is based on 27 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $97.96, with a high forecast of $125.00 and a low forecast of $69.00. The average price target represents a 8.99% upside from the last price of $...
Stay up to date with the latest Gilead Sciences, Inc. stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on GILD here.
Analyst Ratings Sell Under Hold Over Buy Number of Ratings 22 Full Ratings Recent News MarketWatch Dow Jones Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial Dec. 17, 2024 at 2:24 p.m. ET Gilead Sciences Names Sanofi's Berger as Next Chief Medical Officer Dec. ...
Get Gilead Sciences Inc (GILD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
10.74 While his salary and bonus in 2011 were an impressive $4 million, 83% of his compensation came from price gains in his Gilead stock holdings. The astronomical price tags on Gilead's HCV cures boosted Gilead's stock price75 and Martin's net worth with it. By 2014, he was worth ...
The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA. Competitors NameChg %Market Cap Bio-Techne Corp. -0.35% $12.09B Incyte Corp. -0.75% $13.96B Gilead Sciences Inc. 0.21% $114.22B...